Institutional Ownership
Perspective Therapeutics Inc
CUSIP 46489V302COM NEWCATXQ1 2026
13D / 13G Filings
16
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
14.1%
Max % of class reported
Institutional Holders
131
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
16 filings · latest Mar 10, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 10, 2026 | Avidity Partners Management LP | 13G | 5.3% | — | SEC |
| 2 | Feb 12, 2026 | Morgan Stanley | 13G | 6.0% | 4.46M | SEC |
| 3 | Feb 9, 2026 | Commodore Capital LP | 13G | 11.0% | 11.94M | SEC |
| 4 | Feb 6, 2026 | Tcg Crossover Gp II, LLC | 13G | 11.0% | 7.92M | SEC |
| 5 | Feb 5, 2026 | Qatar Investment Authority | 13G | 6.2% | 7.07M | SEC |
| 6 | Dec 5, 2025 | Fmr LLC | 13G/A | 0.4% | 312.2K | SEC |
| 7 | Nov 7, 2025 | Fmr LLC | 13G/A | 8.2% | 6.06M | SEC |
| 8 | Feb 14, 2025 | Janus Henderson Group PLC | 13G/A | — | 17.8K | SEC |
| 9 | Feb 14, 2025 | Avidity Partners Management LP | 13G/A | 4.2% | — | SEC |
| 10 | Nov 14, 2024 | Commodore Capital LP | 13G/A | 5.0% | 3.35M | SEC |
6 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Perspective Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Tcg Crossover Management, LLC | 7.92M | $33.01M |
| 2 | Commodore Capital LP | 6.34M | $26.42M |
| 3 | Avidity Partners Management LP | 6.05M | $25.23M |
| 4 | Blackrock, Inc. | 5.35M | $22.30M |
| 5 | Opaleye Management Inc. | 4.67M | $19.49M |
| 6 | Millennium Management LLC | 4.05M | $16.87M |
| 7 | Citadel Advisors LLC | 3.57M | $14.87M |
| 8 | Affinity Asset Advisors, LLC | 3.16M | $13.20M |
| 9 | State Street Corp | 3.13M | $13.06M |
| 10 | Balyasny Asset Management L.P. | 2.99M | $12.49M |